Atlas Trials

PRS-343 in HER2-Positive Solid Tumors

Clinical trial NCT03330561 · COMPLETED

Trial details

NCT number
NCT03330561
Sponsor
Pieris Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Bladder CancerHER2-positive Solid Tumor
Start date
2017-09-13
Primary completion
2023-12-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.